SEC Tracker
Get the app

Naploy NPLY

Naploy FY 2024: revenue $0; diluted EPS −$0.01

Form
10-K
Filed
Period
Importance
Notable
Document
10-K

Key figures from this report

These are the numbers Naploy reported for the year ended Jul 31, 2024, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Revenue$0No year-earlier figure tagged10-K income statement, on EDGAR
  2. Net income−$20KNo year-earlier figure tagged10-K income statement, on EDGAR
  3. Diluted EPS−$0.01No year-earlier figure tagged10-K income statement, on EDGAR
  4. Cash and cash equivalents$32KNo year-earlier figure tagged10-K balance sheet, on EDGAR
  5. Cash from operations−$17KNo year-earlier figure tagged10-K cash flow statement, on EDGAR

Every year in the financial tables

View on EDGAR

Open in the app

Get an email when Naploy files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8000 and related industry codes: the same peer list as the financial tables.

  1. Alps Group ALPS
  2. American Oncology Network AONC
  3. Agape ATP ATPC public float $5M, Dec 31, 2025
  4. Anew Health AVG
  5. Better Therapeutics BTTX